Elevated Invasive Potential of Glioblastoma Stem Cells

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 2011 Mar 5

PMID 21371437

Citations 118

Authors

Lin Cheng

Qiulian Wu

Olga A Guryanova

Zhi Huang

Qian Huang

Jeremy N Rich

Shideng Bao

Affiliations

Soon will be listed here.

Abstract

Glioblastomas (GBMs) are the most lethal and common types of primary brain tumors. The hallmark of GBMs is their highly infiltrative nature. The cellular and molecular mechanisms underlying the aggressive cancer invasion in GBMs are poorly understood. GBM displays remarkable cellular heterogeneity and hierarchy containing self-renewing glioblastoma stem cells (GSCs). Whether GSCs are more invasive than non-stem tumor cells and contribute to the invasive phenotype in GBMs has not been determined. Here we provide experimental evidence supporting that GSCs derived from GBM surgical specimens or xenografts display greater invasive potential in vitro and in vivo than matched non-stem tumor cells. Furthermore, we identified several invasion-associated proteins that were differentially expressed in GSCs relative to non-stem tumor cells. One of such proteins is L1CAM, a cell surface molecule shown to be critical to maintain GSC tumorigenic potential in our previous study. Immunohistochemical staining showed that L1CAM is highly expressed in a population of cancer cells in the invasive fronts of primary GBMs. Collectively, these data demonstrate the invasive nature of GSCs, suggesting that disrupting GSCs through a specific target such as L1CAM may reduce GBM cancer invasion and tumor recurrence.

Citing Articles

Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2.

Lv D, Dixit D, Cruz A, Kim L, Duan L, Xu X Cell Metab. 2024; 36(11):2419-2436.e8.

PMID: 39454581 PMC: 11726586. DOI: 10.1016/j.cmet.2024.09.014.

Targeting glioblastoma with a brain-penetrant drug that impairs brain tumor stem cells via NLE1-Notch1 complex.

Burban A, Sharanek A, Hernandez-Corchado A, Najafabadi H, Soleimani V, Jahani-Asl A Stem Cell Reports. 2024; 19(11):1534-1547.

PMID: 39423824 PMC: 11589194. DOI: 10.1016/j.stemcr.2024.09.007.

Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies.

Agosti E, Antonietti S, Ius T, Fontanella M, Zeppieri M, Panciani P Int J Mol Sci. 2024; 25(14.

PMID: 39063221 PMC: 11276876. DOI: 10.3390/ijms25147979.

The role of lactate-induced protein lactylation in gliomas: implications for preclinical research and the development of new treatments.

Liu X, Zhou Y, Wang H Front Pharmacol. 2024; 15:1383274.

PMID: 38983918 PMC: 11231103. DOI: 10.3389/fphar.2024.1383274.

Dissecting TGF-β-induced glioblastoma invasion with engineered hyaluronic acid hydrogels.

Amofa K, Patterson K, Ortiz J, Kumar S APL Bioeng. 2024; 8(2):026125.

PMID: 38894960 PMC: 11184968. DOI: 10.1063/5.0203213.

References

Cheng L, Wu Q, Huang Z, Guryanova O, Huang Q, Shou W . L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J. 2011; 30(5):800-13. PMC: 3049209. DOI: 10.1038/emboj.2011.10. View

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6):501-13. PMC: 2693960. DOI: 10.1016/j.ccr.2009.03.018. View

Xia H, Qi Y, Ng S, Chen X, Li D, Chen S . microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 2009; 1269:158-65. DOI: 10.1016/j.brainres.2009.02.037. View

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon R . Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008; 68(15):6043-8. PMC: 2739001. DOI: 10.1158/0008-5472.CAN-08-1079. View

Park D, Sathornsumetee S, Rich J . Medical oncology: treatment and management of malignant gliomas. Nat Rev Clin Oncol. 2010; 7(2):75-7. DOI: 10.1038/nrclinonc.2009.221. View

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T . L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005; 168(4):633-42. PMC: 2171754. DOI: 10.1083/jcb.200408051. View

Furnari F, Fenton T, Bachoo R, Mukasa A, Stommel J, Stegh A . Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007; 21(21):2683-710. DOI: 10.1101/gad.1596707. View

Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland A . Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006; 66(16):7843-8. DOI: 10.1158/0008-5472.CAN-06-1010. View

Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir I . Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006; 5:67. PMC: 1697823. DOI: 10.1186/1476-4598-5-67. View

10.

Raveh S, Gavert N, Ben-Zeev A . L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 2009; 282(2):137-45. DOI: 10.1016/j.canlet.2008.12.021. View

11.

Bao S, Wu Q, McLendon R, Hao Y, Shi Q, Hjelmeland A . Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444(7120):756-60. DOI: 10.1038/nature05236. View

12.

Esselens C, Malapeira J, Colome N, Casal C, Rodriguez-Manzaneque J, Canals F . The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration. J Biol Chem. 2009; 285(4):2463-73. PMC: 2807303. DOI: 10.1074/jbc.M109.055129. View

13.

Muerkoster S, Kotteritzsch J, Geismann C, Gast D, Kruse M, Altevogt P . alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma. Int J Oncol. 2008; 34(1):243-53. View

14.

Folkins C, Shaked Y, Man S, Tang T, Lee C, Zhu Z . Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res. 2009; 69(18):7243-51. PMC: 3409689. DOI: 10.1158/0008-5472.CAN-09-0167. View

15.

Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin N . Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell. 2006; 9(5):391-403. DOI: 10.1016/j.ccr.2006.03.030. View

16.

Singh S, Hawkins C, Clarke I, Squire J, Bayani J, Hide T . Identification of human brain tumour initiating cells. Nature. 2004; 432(7015):396-401. DOI: 10.1038/nature03128. View

17.

Schmid R, Maness P . L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol. 2008; 18(3):245-50. PMC: 2633433. DOI: 10.1016/j.conb.2008.07.015. View

18.

Cheng L, Bao S, Rich J . Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol. 2010; 80(5):654-65. PMC: 2897968. DOI: 10.1016/j.bcp.2010.04.035. View

19.

Wen P, Kesari S . Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507. DOI: 10.1056/NEJMra0708126. View

20.

Stoeck A, Gast D, Sanderson M, Issa Y, Gutwein P, Altevogt P . L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol. 2006; 104(2):461-9. DOI: 10.1016/j.ygyno.2006.08.038. View